{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:04:20Z","timestamp":1789387460683,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070243"],"award-info":[{"award-number":["82070243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.cjca.2023.11.004","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T14:09:17Z","timestamp":1699366157000},"page":"613-621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treprostinil Effectiveness in Higher-Risk Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"40","author":[{"given":"Yuan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley B.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2023.11.004_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.111.026591","article-title":"Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"issue":"9815","key":"10.1016\/j.cjca.2023.11.004_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(11)61621-8","article-title":"Clinical features of paediatric pulmonary hypertension: a registry study","volume":"379","author":"Berger","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.11.004_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"d\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2023.11.004_bib4","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.pcl.2020.06.005","article-title":"Pediatric pulmonary arterial hypertension","volume":"67","author":"Frank","year":"2020","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.cjca.2023.11.004_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.amjcard.2010.02.023","article-title":"Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies","volume":"106","author":"van Loon","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.11.004_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.001887","article-title":"Exome sequencing in children with pulmonary arterial hypertension demonstrates differences compared with adults","volume":"11","author":"Zhu","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.cjca.2023.11.004_bib7","first-page":"1851","article-title":"Genotypes and phenotypes of Chinese pediatric patients with idiopathic and heritable pulmonary arterial hypertension\u2014a single-center study","volume":"35","author":"Zhang","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2023.11.004_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpeds.2020.05.051","article-title":"The genetic epidemiology of pediatric pulmonary arterial hypertension","volume":"225","author":"Haarman","year":"2020","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cjca.2023.11.004_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211044577","article-title":"Clinical characteristics and prognosis analysis of idiopathic and hereditary pulmonary hypertension patients with ACVRL1 gene mutations","volume":"11","author":"Zhang","year":"2021","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cjca.2023.11.004_bib10","first-page":"7331","article-title":"Association between genotype, presentation, and outcome in childhood idiopathic and hereditary pulmonary arterial hypertension","volume":"11","author":"Xu","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cjca.2023.11.004_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01916-2018","article-title":"Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management","volume":"53","author":"Rosenzweig","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2023.11.004_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2018.03.067","article-title":"Safety, efficacy and Management of subcutaneous treprostinil infusions in the treatment of severe pediatric pulmonary hypertension","volume":"264","author":"Levy","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2023.11.004_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jpeds.2010.09.025","article-title":"Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension","volume":"158","author":"Levy","year":"2011","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cjca.2023.11.004_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"ESC\/ERS Scientific Document Group. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2023.11.004_bib15","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1164\/rccm.201902-0266LE","article-title":"The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension","volume":"200","author":"Haarman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjca.2023.11.004_bib16","first-page":"23","article-title":"Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension","volume":"56","author":"Liu","year":"2018","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.cjca.2023.11.004_bib18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.chest.2022.11.038","article-title":"Characteristics, long-term survival and risk assessment of pediatric pulmonary arterial hypertension in China: Insights from a national multicenter prospective registry","volume":"163","author":"Qian","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2023.11.004_bib19","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.transproceed.2021.01.047","article-title":"Prognostic value of early risk stratification in pediatric pulmonary arterial hypertension","volume":"53","author":"Ablonczy","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cjca.2023.11.004_bib20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.amjcard.2012.04.035","article-title":"Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers","volume":"110","author":"Chida","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.11.004_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018759247","article-title":"Right ventricular function mirrors clinical improvement with use of prostacyclin analogues in pediatric pulmonary hypertension","volume":"8","author":"Hopper","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cjca.2023.11.004_bib22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.healun.2013.01.1055","article-title":"Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics","volume":"32","author":"Siehr","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2023.11.004_bib24","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2014.02.575","article-title":"Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies","volume":"63","author":"Zijlstra","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.11.004_bib25","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01120-2020","article-title":"Upfront triple combination therapy in severe paediatric pulmonary arterial hypertension","volume":"57","author":"Haarman","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjca.2023.11.004_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810433","article-title":"Clinical implications of the genetic background in pediatric pulmonary arterial hypertension: data from the Spanish REHIPED registry","volume":"23","author":"Cruz-Utrilla","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cjca.2023.11.004_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1513\/AnnalsATS.202012-1563OC","article-title":"Parenteral prostanoids in pediatric pulmonary arterial hypertension: start early, dose high, combine","volume":"19","author":"Douwes","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cjca.2023.11.004_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020944858","article-title":"Prostanoids in pediatric pulmonary hypertension: clinical response, time-to-effect, and dose-response","volume":"10","author":"Tella","year":"2020","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cjca.2023.11.004_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12224","article-title":"Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients","volume":"13","author":"McSweeney","year":"2023","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cjca.2023.11.004_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.amjcard.2003.12.031","article-title":"Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan","volume":"93","author":"Ivy","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2023.11.004_bib31","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.amjcard.2009.12.075","article-title":"Effectiveness of transition from intravenous epoprostenol to oral\/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension","volume":"105","author":"Melnick","year":"2010","journal-title":"Am J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23018810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23018810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:13:48Z","timestamp":1789384428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X23018810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0828282X23018810"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2023.11.004","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treprostinil Effectiveness in Higher-Risk Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2024.02.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}